Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
Price:
38.94
CNY
-0.43%
Market Closed
Market Cap:
¥6.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
|
CN |
|
S
|
Sunlight Technology Holdings Ltd
HKEX:1950
|
CN |
|
Beigene Ltd
SSE:688235
|
KY |
|
Dafeng TV Ltd
TWSE:6184
|
TW |
|
Gravita India Ltd
NSE:GRAVITA
|
IN |
Income Statement
Earnings Waterfall
Beijing Konruns Pharmaceutical Co Ltd
Beijing Konruns Pharmaceutical Co Ltd
Income Statement
Beijing Konruns Pharmaceutical Co Ltd
Beijing Konruns Pharmaceutical Co Ltd
Currency: CNY
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
4
|
5
|
6
|
6
|
0
|
0
|
0
|
|
| Revenue |
822
N/A
|
897
+9%
|
1 022
+14%
|
1 031
+1%
|
1 078
+5%
|
1 087
+1%
|
1 066
-2%
|
944
-11%
|
870
-8%
|
855
-2%
|
809
-5%
|
949
+17%
|
916
-3%
|
855
-7%
|
810
-5%
|
755
-7%
|
726
-4%
|
801
+10%
|
867
+8%
|
876
+1%
|
946
+8%
|
999
+6%
|
920
-8%
|
954
+4%
|
874
-8%
|
846
-3%
|
825
-2%
|
838
+2%
|
881
+5%
|
871
-1%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||
| Cost of Revenue |
(62)
|
(64)
|
(50)
|
(67)
|
(70)
|
(72)
|
(58)
|
(68)
|
(66)
|
(69)
|
(59)
|
(84)
|
(103)
|
(109)
|
(106)
|
(117)
|
(112)
|
(120)
|
(127)
|
(129)
|
(125)
|
(120)
|
(101)
|
(112)
|
(102)
|
(103)
|
(86)
|
(91)
|
(97)
|
(95)
|
|
| Gross Profit |
761
N/A
|
833
+10%
|
972
+17%
|
964
-1%
|
1 008
+5%
|
1 016
+1%
|
1 008
-1%
|
876
-13%
|
805
-8%
|
786
-2%
|
749
-5%
|
865
+15%
|
813
-6%
|
747
-8%
|
704
-6%
|
638
-9%
|
614
-4%
|
681
+11%
|
740
+9%
|
747
+1%
|
821
+10%
|
879
+7%
|
819
-7%
|
842
+3%
|
772
-8%
|
743
-4%
|
739
-1%
|
747
+1%
|
784
+5%
|
776
-1%
|
|
| Operating Income | |||||||||||||||||||||||||||||||
| Operating Expenses |
(564)
|
(623)
|
(707)
|
(711)
|
(735)
|
(749)
|
(758)
|
(666)
|
(630)
|
(621)
|
(600)
|
(670)
|
(645)
|
(572)
|
(583)
|
(543)
|
(516)
|
(602)
|
(609)
|
(612)
|
(645)
|
(660)
|
(680)
|
(699)
|
(660)
|
(656)
|
(618)
|
(724)
|
(746)
|
(737)
|
|
| Selling, General & Administrative |
(529)
|
(585)
|
(664)
|
(661)
|
(667)
|
(676)
|
(684)
|
(587)
|
(562)
|
(550)
|
(536)
|
(605)
|
(569)
|
(507)
|
(476)
|
(459)
|
(452)
|
(526)
|
(519)
|
(533)
|
(560)
|
(569)
|
(582)
|
(612)
|
(575)
|
(586)
|
(552)
|
(571)
|
(593)
|
(584)
|
|
| Research & Development |
(33)
|
(40)
|
(71)
|
(91)
|
(116)
|
(131)
|
(100)
|
(104)
|
(94)
|
(89)
|
(87)
|
(96)
|
(110)
|
(98)
|
(92)
|
(103)
|
(84)
|
(91)
|
(76)
|
(91)
|
(91)
|
(99)
|
(84)
|
(85)
|
(78)
|
(63)
|
(49)
|
(52)
|
(52)
|
(53)
|
|
| Depreciation & Amortization |
0
|
0
|
(19)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(2)
|
2
|
47
|
41
|
49
|
58
|
45
|
25
|
26
|
18
|
40
|
30
|
34
|
33
|
7
|
18
|
20
|
15
|
13
|
12
|
6
|
8
|
11
|
(1)
|
(7)
|
(7)
|
4
|
(101)
|
(100)
|
(100)
|
|
| Operating Income |
196
N/A
|
210
+7%
|
265
+26%
|
254
-4%
|
274
+8%
|
267
-3%
|
250
-6%
|
210
-16%
|
175
-17%
|
165
-6%
|
149
-10%
|
194
+30%
|
169
-13%
|
175
+4%
|
122
-31%
|
95
-22%
|
98
+3%
|
80
-19%
|
131
+65%
|
135
+2%
|
176
+31%
|
219
+24%
|
139
-36%
|
144
+3%
|
112
-22%
|
87
-22%
|
121
+39%
|
23
-81%
|
39
+68%
|
39
+1%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||
| Interest Income Expense |
16
|
23
|
35
|
55
|
77
|
81
|
63
|
71
|
74
|
67
|
61
|
52
|
37
|
34
|
71
|
79
|
79
|
79
|
10
|
(12)
|
(11)
|
(14)
|
16
|
14
|
12
|
12
|
23
|
23
|
21
|
17
|
|
| Non-Reccuring Items |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(32)
|
0
|
0
|
(0)
|
(105)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
15
|
15
|
0
|
0
|
0
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(4)
|
(3)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(20)
|
(20)
|
(20)
|
(0)
|
(2)
|
(12)
|
(13)
|
|
| Pre-Tax Income |
226
N/A
|
248
+9%
|
300
+21%
|
309
+3%
|
351
+14%
|
347
-1%
|
299
-14%
|
280
-7%
|
247
-12%
|
231
-7%
|
208
-10%
|
245
+18%
|
205
-16%
|
208
+1%
|
189
-9%
|
170
-10%
|
173
+2%
|
156
-10%
|
140
-10%
|
121
-14%
|
163
+35%
|
203
+25%
|
123
-40%
|
138
+12%
|
104
-25%
|
79
-24%
|
39
-51%
|
44
+14%
|
48
+8%
|
43
-10%
|
|
| Net Income | |||||||||||||||||||||||||||||||
| Tax Provision |
(31)
|
(32)
|
(36)
|
(36)
|
(38)
|
(37)
|
(33)
|
(30)
|
(28)
|
(27)
|
(25)
|
(30)
|
(25)
|
(24)
|
(21)
|
(17)
|
(16)
|
(16)
|
(16)
|
(18)
|
(26)
|
(31)
|
65
|
67
|
68
|
69
|
(17)
|
(21)
|
(17)
|
(11)
|
|
| Income from Continuing Operations |
195
|
215
|
264
|
273
|
313
|
311
|
266
|
249
|
220
|
204
|
183
|
216
|
180
|
184
|
167
|
153
|
157
|
140
|
124
|
103
|
137
|
172
|
188
|
205
|
171
|
148
|
22
|
23
|
31
|
32
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(19)
|
(23)
|
(27)
|
(25)
|
(22)
|
(23)
|
(25)
|
(26)
|
(37)
|
(38)
|
(35)
|
(33)
|
21
|
22
|
23
|
25
|
|
| Net Income (Common) |
195
N/A
|
215
+10%
|
264
+23%
|
273
+3%
|
313
+15%
|
311
-1%
|
266
-14%
|
249
-6%
|
220
-12%
|
204
-7%
|
183
-10%
|
216
+18%
|
180
-16%
|
179
-1%
|
148
-17%
|
130
-12%
|
130
0%
|
114
-12%
|
101
-11%
|
81
-20%
|
112
+39%
|
146
+30%
|
150
+3%
|
166
+11%
|
137
-18%
|
115
-16%
|
42
-63%
|
45
+7%
|
54
+20%
|
57
+6%
|
|
| EPS (Diluted) |
1.62
N/A
|
1.61
-1%
|
1.98
+23%
|
1.7
-14%
|
1.95
+15%
|
1.95
N/A
|
1.66
-15%
|
1.56
-6%
|
1.38
-12%
|
1.28
-7%
|
1.15
-10%
|
1.35
+17%
|
1.13
-16%
|
1.15
+2%
|
0.94
-18%
|
0.83
-12%
|
0.83
N/A
|
0.73
-12%
|
0.65
-11%
|
0.52
-20%
|
0.72
+38%
|
0.94
+31%
|
0.95
+1%
|
1.06
+12%
|
0.86
-19%
|
0.75
-13%
|
0.27
-64%
|
0.28
+4%
|
0.34
+21%
|
0.35
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
